Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Urothelial Cancer (T2-4 N0-2 M0) of the Bladder

Learn more:

• clinicaltrials.gov: #NCT02891161
• See Study Locations on Big Ten CRC Website